Table 4.
Program changes in glycemic level, weight, and program acceptability by gender, diabetes status, and attendance
| Total | Gender | P-value | Diabetes Status | P-value | Attendance (Educational Sessions) |
P-value | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean ± SD | Men Mean ± SD |
Women Mean ± SD |
T2DM Mean ± SD |
Prediabetes Mean ± SD |
≤ 50% (16) Mean ± SD |
≥75% (17-22) Mean ± SD |
||||
| n | 94 | 25 | 69 | 56 | 38 | 57 | 37 | |||
| Number of sessions attended | 13.7 ± 6.1 | 13.5 ± 6.1 | 13.8 ± 6.1 | 0.82 | 14.0 ± 5.9 | 13.3 ± 6.3 | 0.57 | 10.0 ± 4.9 | 19.4 ± 1.5 | < 0.001 |
| 12-Month Weight change, lbs* | −4.4 ± 11.5 | −4.4 ± 6.1 | −4.5 ± 9.0 | 0.95 | −5.6 ± 11.0 | −2.5 ± 12.4 | 0.26 | −4.71 ± 12.2 | −4.04 ± 10.7 | 0.80 |
| 12-Month HbA1c % change** | −0.21 ± 0.47 | −0.17 ± 0.32 | −0.23 ± 0.52 | 0.62 | −0.41 ± 0.5 | −0.07 ± 0.2 | < 0.001 | −0.13 ± 0.4 | −0.35 ± 0.6 | 0.04 |
| Program benefit | 5.4 ± 0.48 | 5.3 ± 0.54 | 5.4 ± 0.45 | 0.54 | 5.4 ± 0.53 | 5.5 ± 0.37 | 0.19 | 5.3 ± 0.57 | 5.4 ± 0.33 | 0.17 |
| Program satisfaction | 5.1 ± 0.37 | 5.2 ± 0.38 | 5.1 ± 0.37 | 0.47 | 5.1 ± 0.40 | 5.3 ± 0.28 | 0.03 | 5.0 ± 0.39 | 5.2 ± 0.33 | 0.05 |
| Program barriers | 4.3 ± 1.1 | 4.7 ± 0.67 | 4.2 ± 1.2 | 0.08 | 4.3 ± 1.1 | 4.4 ± 1.2 | 0.61 | 4.0 ± 1.1 | 4.7 ± 0.95 | 0.008 |
| Baseline Body Mass Index | 36.8 ± 7.7 | 36.6 ± 6.8 | 36.9 ± 8.1 | 0.88 | 36.9 ± 7.7 | 37.87 ± 8.7 | 0.42 | 39.9 ± 7.73 | 32.5 ± 5.6 | < 0.001 |
P-value= difference between groups; * Weight loss (lbs) was assessed by difference in 12-month and baseline value. A negative estimate indicates greater weight loss. ** HbA1c % change was assessed by difference in 12-month and baseline value. A negative estimate indicates greater reduction in HbA1c value. Program benefit was assessed with a Likert scale (7 items), barriers to session attendance (5 items), and overall program satisfaction (1 item), post-program (range was 1–5). Items were summed with higher score indicating higher benefits and overall satisfaction, and lower barriers. Sample size includes 94 adults with diabetes and prediabetes. Attendance included number of DPM sessions attended in 12 months (range 1–22 educational sessions.